Weislow Pharmaceutical Services LLC Vienna, VA - 22182

Weislow Pharmaceutical Services LLC is categorized under Commercial Medical Research in Vienna, VA and active since 2002.

Weislow Pharmaceutical Services LLC was established in 2002, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.

If you are seeking more information, feel free to contact Owen S Weislow Phd at the company’s single location by writing to 1282 Cobble Pond Way, Vienna, Virginia VA 22182 or by phoning (703) 795-7624. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Weislow Pharmaceutical Services LLC
Contact Person: Owen S Weislow Phd
Address: 1282 Cobble Pond Way, Vienna, Virginia 22182
Phone Number: (703) 795-7624
Annual Revenue (USD): $50.000 to $99.999
Founded: 2002
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Medical Research
SIC Code: 8731
NAICS Code: 541712
Share This Business:

Weislow Pharmaceutical Services LLC was started in 2002 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Owen S Weislow Phd for inquiries that concern Weislow Pharmaceutical Services LLC by calling the company number (703) 795-7624, as your correspondence is most welcome. Additionally, the physical location of the single location of Weislow Pharmaceutical Services LLC can be found at the coordinates as well as the street address 1282 Cobble Pond Way in Vienna, Virginia 22182.

For its online presence, you may visit Weislow Pharmaceutical Services LLC’s website at and engage with its social media outlets through on Twitter and on Facebook.